Remove Doctors Remove Insulin Remove Production
article thumbnail

World Diabetes Day 2024: Advanced Care for Diabetes Management

XTalks

Cure Research: Moving Toward an Insulin-Free Future JDRF is focused on funding research that is accelerating the development of new treatments for people with T1D — for all ages and stages. “Our before people need insulin therapy), so that it’s possible to intervene with therapies that can stop clinical disease before it starts.”

Insulin 108
article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. Continuing advancements within this field deliver new hope to doctors and patients, transforming disease outcomes for previously incurable indications.

Drugs 295
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA approves Lyumjev® (insulin lispro-aabc injection) 100 units/mL for use in insulin pumps

The Pharma Data

approval of pump use for Lilly’s novel insulin is latest development designed to help people with diabetes manage blood sugar levels. Lyumjev, a novel formulation of insulin lispro developed to speed the absorption of insulin into the bloodstream and reduce A1C levels, was approved by the FDA in June 2020.

Insulin 52
article thumbnail

The US biosimilar market: Predictions for 2021

pharmaphorum

As we’ve seen over those five years, biosimilars are critical in continuing to provide doctors and patients choice in their care plans as well as continuing to decrease overall healthcare costs. One of these markets is the insulin market. Americans pay ten times as much for insulin as Canadian patients do.

Marketing 119
article thumbnail

MIOTIFY platform for digital health products clears AZ road test

pharmaphorum

UK company MIOTIFY has developed a web-based software platform that product teams can use to configure medical algorithms quickly, create code packages to harness them and generate supporting documentation – all in a format that is designed to meet regulatory requirements for software as a medical device (SaMD). .

article thumbnail

Medtronic Introduces New Minimed 770G For Type 1 Diabetes

XTalks

This is an insulin pump system that offers the company’s most advanced SmartGuard technology. Furthermore, the notices can also be automatically shared with clinicians and educators to help facilitate more effective telehealth visits and product trainings. ” The pancreas of people with type 1 diabetes cannot produce insulin.

Insulin 98
article thumbnail

The Longevity Breakthrough Your Doctor Won't Tell You About

The Pharma Data

Product Name: The Longevity Breakthrough Your Doctor Won't Tell You About. The Longevity Breakthrough Your Doctor Won't Tell You About is backed with a 60 Day No Questions Asked Money Back Guarantee. One French scientists concluded that this ingredient contains something which stimulates the growth of cancerous tumors!

Doctors 52